Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: The experience of a single center in Brazil

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 7, 2004, Pages 462-468

  Klumb, Claudete Esteves ^a,b   Schramm, Márcia Trindade ^a   Magalhães De Resende, Lidia Maria ^a   Carriço, Maria Kadma ^a   Coelho, Arthur Moellman ^a   De Meis, Ernesto ^a   Ferreira, Regina Moreira ^a   Maia, Raquel Ciuvalschi ^a   De Almeida Dobbin, Jane ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b Instituto Estadual de Hematologia   (Brazil)

Author keywords

Burkitt's lymphoma; Childhood; Non Hodgkin's B cell lymphoma; Therapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; MESNA; METHOTREXATE; PREDNISONE; VINDESINE;

ADOLESCENT; ARTICLE; B CELL LYMPHOMA; BACTEREMIA; BLOOD TOXICITY; BRAZIL; BURKITT LYMPHOMA; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; DEATH; DEVELOPING COUNTRY; DRUG DOSE REDUCTION; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HERPES VIRUS INFECTION; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUCOSA INFLAMMATION; MYCOBACTERIOSIS; MYCOSIS; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SIDE EFFECT; URINARY TRACT INFECTION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BRAZIL; CHILD; CHILD, PRESCHOOL; DAUNORUBICIN; FEMALE; HUMANS; INFANT; LYMPHOMA, B-CELL; MALE; NEOPLASM STAGING; PREDNISONE; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 3543147868     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200407000-00014     Document Type: Article

References (25)

1. Reiter A, Scharappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Münster Group trial NHL-BFM 90. Blood. 1999;94:3294-3306.
2. Patte C, Auperin A, Michon J, et al. The Societé Française d' Pédiatric LMB89 protocol: highly effective multiagent chemotherapy tailored to tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001;97:3370-3379.
3. Cairo MS, Sposto R, Perkins SL, et al. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of Children's Cancer Group experience. Br J Haematol. 2003;120:660-670.
4. Patte C. Treatment of mature B-ALL and high-grade B-NHL in children. Best Pract Res Clin Haematol. 2002;15:695-711.
5. Van Hasselt EJ, Broadhead R. Burkitt's lymphoma: a case file study of 160 patients treated in Queen Elizabeth Central Hospital from 1988-1992. Pediarr Hematol Oncol. 1995;12:277-281.
6. Ertem U, Duru F, Pamir A, et al. Burkitt's lymphoma in 63 Turkish children diagnosed over a 10-year period. Pediatr Hematol Oncol. 1996;13:123-134.
7. Hesseling PB. The SIOP Burkitt lymphoma pilot study in Malawi, Africa. Med Pediatr Oncol. 2000;34:142.
8. De Andrea ML, de Camargo B, Correa AA, et al. Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach. Cancer. 1988;62:240-250.
9. Sandlung JT, Fonseca T, Leiming T, et al. Predominace and characteristics ofBurkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil. Leukemia. 1997;11:743-746.
10. Kazembe P, Hesseling PB, Griffin BE, et al. Long-term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy. Med Pediatr Oncol. 2003;40:23-25.
11. Hesseling PB. High-dose intense chemotherapy in South African children with B-cell lymphoma: morbidity, supportive measures, and outcome. Med Pediatr Oncol. 2000;34:143-146.
12. De Andrea ML, Camargo B, Melaragno R. A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminary evaluation. J Clin Oncol. 1990;8:666-671.
13. th International Cancer Congress. Rio de Janeiro, 1998.
14. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
15. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphoma in adults. Semin Oncol. 1980;7:332-339.
16. Paes CA, Viana MB, Freire RV, et al. Direct association of socioeconomic status with T-cell lymphoblastic leukaemia in children. Leuk Res. 2003;27:789-794.
17. Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group. J Clin Oncol. 1995;13:359-372.
18. Instituto Brasileiro de Geografia e Estatística-IBGE. Departamento de População e Indicadores sociais. Available at: URL:http://www.ibge.gov.br/. Accessed Sept. 9, 2003.
19. Bretcher ML, Schwenn MR, Coopes MJ, et al. Fractionated cyclophosphamide and back high-dose methotrexate and cytosine arabinoside improves outcome in patients with stage II stage small non-cleaved cell lymphomas (Snccl): a randomized trial of Pediatric Oncology Group. Med Pediatr Oncol. 1997;29:526-533.
20. Wessels G, Hesseling PB. High-dose intense chemotherapy in South African children with B-cell lymphoma: morbidity, supportive measures, and outcome. Med Pediatr Oncol. 2000;34:143-146.
21. Chantada LG, Felice MS, Zubizarreta PA, et al. Results of a BFM-based protocol for the treatment of childhood B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukemia in Argentina. Med Pediatr Oncol. 1997;28:333-341.
22. Kavan P, Kabickova E, Gajdos P, et al. Treatment of pediatric B-cell nonHodgkin's lymphomas at the Motol Hospital in Prague, Czech Republic: results based on the NHL BFM 90 protocols. Pediatr Hematol Oncol. 1999;16:201-212.
23. Spreafico F, Massimino M, Luksch R, et al. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children. J Clin Oncol. 2002;20:2783-2788.
24. Dieckvoss BO, Stanulla M, Schrappe M, et al. Polymorphism within glutation S-tranferases genes in pediatric non-Hodgkin's lymphoma. Haematologica. 2002;87:709-713.
25. Klumb CE, Furtado DR, de Resende LM, et al. DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin's lymphomas: prognostic implications. Eur J Haematol. 2003;71:81-90.